1. Home
  2. TLPH

as 05-24-2024 3:32pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Founded: 2005 Country:
United States
United States
Employees: 15 City: SAN MATEO
Market Cap: 17.5M IPO Year: 2011
Target Price: $4.50 AVG Volume (30 days): 72.5K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.85 EPS Growth: N/A
52 Week Low/High: $0.43 - $1.61 Next Earning Date: 05-14-2024
Revenue: $651,000 Revenue Growth: N/A
Revenue Growth (this year): 6.94% Revenue Growth (next year): 266.87%

Share on Social Networks: